Exodus Point Capital Management, LP Mersana Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.0 - $4.45 $214,348 - $476,924	107,174 New	107,174 $215,000
Q1 2023 May 11, 2023	BUY	$4.0 - $7.02 $112,940 - $198,209	28,235 Added 239.3%	40,034 $165,000
Q4 2022 Feb 13, 2023	SELL	$5.65 - $7.86 $822,707 - $1.14 Million	-145,612 Reduced 92.5%	11,799 $69,000
Q3 2022 Nov 10, 2022	BUY	$4.63 - $8.0 $610,613 - $1.06 Million	131,882 Added 516.6%	157,411 $1.06 Million
Q2 2022 Aug 19, 2022	SELL	$2.84 - $5.0 $714,430 - $1.26 Million	-251,560 Reduced 90.79%	25,529 $118,000
Q1 2022 May 13, 2022	BUY	$3.74 - $6.63 $922,575 - $1.64 Million	246,678 Added 811.15%	277,089 $1.11 Million
Q4 2021 Feb 11, 2022	BUY	$5.48 - $9.86 $166,652 - $299,852	30,411 New	30,411 $189,000
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $181,018 - $305,997	-21,147 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $280,832 - $382,126	21,147 New	21,147 $287,000
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $500,698 - $867,310	-32,704 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $206,357 - $338,087	-12,254 Reduced 27.26%	32,704 $870,000
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $728,319 - $1.16 Million	44,958 New	44,958 $837,000
Q2 2019 Aug 14, 2019	SELL	$3.84 - $6.4 $209,272 - $348,787	-54,498 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.51 - $7.3 $191,287 - $397,835	54,498 New	54,498 $287,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $192M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.